Ensho Therapeutics, Inc. — Form D
Ensho Therapeutics, Inc. of Woodcliff Lake, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-09. The offering totals $20.0M. Industry: Biotechnology.
Offering
- Filed: 2026-02-09
- Form: D
- Accession: 0002032849-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Remaining: $20.0M
- Minimum investment: $1
- Investors: 9
- Date of first sale: 2026-01-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-572987
Issuer
- Name: Ensho Therapeutics, Inc.
- CIK: 0002032849
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 50 Tice Boulevard, Woodcliff Lake, NJ, 07677
- Phone: 973-475-8970
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Gerhard Hagn | Executive Officer | Woodcliff Lake, NJ |
| Neena Bitritto-Garg | Director | Morris Plains, NJ |
| Neena Bitritto-Garg | Executive Officer | Morris Plains, NJ |
| Neena Bitritto-Garg | Promoter | Morris Plains, NJ |
| Emily Weng | Executive Officer | Morris Plains, NJ |
| Eric Pham | Director | Woodcliff Lake, NJ |
| Matthew McKevitt | Executive Officer | Morris Plains, NJ |
| Arash Rassoulpour | Director | Woodcliff Lake, NJ |
| Carlos Solorzano | Director | Woodcliff Lake, NJ |
| James Whitney | Executive Officer | Morris Plains, NJ |
| Danielle Fry | Executive Officer | Woodcliff Lake, NJ |
| Bittoo Kanwar | Executive Officer | Morris Plains, NJ |
| Danielle Andrew Fry | Executive Officer | Morris Plains, NJ |
| Matthew Andrew McKevitt | Executive Officer | Morris Plains, NJ |
| James Andrew Whitney | Executive Officer | Morris Plains, NJ |
| Emily Andrew Weng | Executive Officer | Morris Plains, NJ |
Other filings by this issuer (3)
More